Zeid Abdallah M, Kaji Noritada, Nasr Jenny Jeehan M, Belal Fathalla F, Baba Yoshinobu, Walash Mohamed I
Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan; ImPACT Research Center for Advanced Nanobiodevices, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan; JST, PRESTO, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.
J Chromatogr A. 2017 Jun 23;1503:65-75. doi: 10.1016/j.chroma.2017.04.049. Epub 2017 Apr 26.
A facile, rapid, and highly sensitive microchip-based electrokinetic chromatographic method was developed for the simultaneous analysis of two gabapentinoid drugs, gabapentin (GPN) and pregabalin (PGN). Both drugs were first reacted with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) via nucleophilic substitution reactions to yield highly fluorescent products with λ 470/540nm. Analyses of both fluorescently labeled compounds were achieved within 200s in a poly(methyl methacrylate) (PMMA) microchip with a 30mm separation channel. Optimum separation was achieved using a borate buffer (pH 9.0) solution containing methylcellulose and β-cyclodextrin (β-CD) as buffer additives. Methylcellulose acted as a dynamic coating to prevent adsorption of the studied compounds on the inner surfaces of the microchannels, while β-CD acted as a pseudo-stationary phase to improve the separation efficiency between the labeled drugs with high resolution (Rs>7). The fluorescence intensities of the labeled drugs were measured using a light emitting diode-induced fluorescence detector at 540nm after excitation at 470nm. The sensitivity of the method was enhanced 14- and 17-fold for PGN and GPN, respectively by field-amplified stacking relative to traditional pinched injection so that it could quantify 10ngmL for both analytes, with a detection limit lower than 3ngmL. The developed method was efficiently applied to analyze PGN and GPN in their pharmaceutical dosage forms and in biological fluids. The extraction recoveries of the studied drugs from plasma and urine samples were more than 89% with%RSD values lower than 6.2.
开发了一种简便、快速且高灵敏度的基于微芯片的电动色谱方法,用于同时分析两种加巴喷丁类药物,即加巴喷丁(GPN)和普瑞巴林(PGN)。两种药物首先通过亲核取代反应与4-氟-7-硝基-2,1,3-苯并恶二唑(NBD-F)反应,生成具有470/540nm波长的高荧光产物。在具有30mm分离通道的聚甲基丙烯酸甲酯(PMMA)微芯片中,200s内即可完成对两种荧光标记化合物的分析。使用含有甲基纤维素和β-环糊精(β-CD)作为缓冲添加剂的硼酸盐缓冲液(pH 9.0)实现了最佳分离。甲基纤维素作为动态涂层,可防止所研究的化合物吸附在微通道内表面,而β-CD作为假固定相,可提高标记药物之间的分离效率,实现高分辨率分离(Rs>7)。在470nm激发后,使用发光二极管诱导荧光检测器在540nm处测量标记药物的荧光强度。与传统的夹心法进样相比,通过场放大堆积,该方法对PGN和GPN的灵敏度分别提高了14倍和17倍,因此两种分析物的定量限均为10ng/mL,检测限低于3ng/mL。所开发的方法有效地应用于分析药物剂型和生物流体中的PGN和GPN。从血浆和尿液样品中提取所研究药物的回收率超过89%,相对标准偏差(%RSD)值低于6.2。